Effects of chronic treatment with the new ultra‐long‐acting β2‐adrenoceptor agonist indacaterol alone or in combination with the β1‐adrenoceptor blocker metoprolol on cardiac remodelling

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|14|3627-3637

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.14, 2015-07, pp. : 3627-3637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The long‐acting β2‐adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor‐mediated transcription in human airway epithelial cells in a gene‐ and agonist‐dependent manner

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2634-2653

John Wiley & Sons Inc

Access to resources Recommend Favorite

The long‐acting β2‐adrenoceptor agonist olodaterol attenuates pulmonary inflammation

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 14, 2015-07 ,pp. : 3537-3547

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative partial agonist activity of β‐adrenoceptor antagonists

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 45, Iss. 2, 1972-06 ,pp. : 382-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhaled Corticosteroid/Long-Acting β2-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe

By  

International Archives of Allergy and Immunology, Vol. 157, Iss. 3, 2011-11 ,pp. : 303-310

Karger

Access to resources Recommend Favorite

Indacaterol, a novel inhaled, once-daily, long-acting beta 2 -agonist for the treatment of obstructive airways diseases

By Beeh Kai  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite